查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463060

遲發性運動障礙治療藥物市場,佔有率,規模,趨勢,行業分析報告:依藥物,產品類型,銷售管道,地區,細分市場,預測2024-2032年

Tardive Dyskinesia Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug (Deutetrabenazine, Valbenazine, and Others); By Product Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球治療遲發性運動障礙的藥物市場預計將達到 55.7 億美元。該報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

各種神經系統和精神疾病的盛行率迅速增加以及對新型疾病特異性治療的需求不斷增加是推動市場成長的關鍵因素。此外，增加對研究人員和醫療機構的財政支持，以推進醫療保健領域的新穎干預措施和創新，包括遲發性運動障礙治療，預計將進一步推動市場成長。

例如，2023 年 11 月，Neurocrine Biosciences 推出了 DISCOVER TD，這是一種互動式數位工具，專門用於幫助醫療保健專業人員瞭解和識別遲發性運動障礙。該工具是與臨床專家合作開發的。

世界各地需要長期使用抗精神病藥物治療、導致多巴胺水平不正常的精神疾病病例不斷增加，增加了對有效治療的需求。越來越多地採用神經心理學測驗來監測和檢測認知功能的變化、識別特定模式並提高資訊處理速度，這也推動了市場的成長。例如，根據美國疾病管制與預防中心的報告，美國近五分之一的成年人患有某種形式的精神疾病，近五分之一的年輕人在一生中會經歷嚴重的精神疾病。我有精神疾病。

最近，美國神經病學會指南進行了更新，納入了兩種 FDA 批准的 VMAT2 抑制劑，包括伐苯那秦和氘苯那秦。這些藥物是第一個獲得 A 級證據支持的藥物，主要在美國被批准用於治療遲發性運動障礙。

遲發性運動障礙治療藥物市場報告亮點

由於人們對遲發性運動障礙及其治療藥物的認識不斷提高，伐苯那秦製劑擁有顯著的市場佔有率

由於醫療專業人員越來越多地採用和高劑量功效，固體劑量部分佔據了大部分佔有率

由於線上買家的增加以及偏遠地區線上藥局的出現，線上藥局產業預計將以最快的速度成長。

北美由於對該疾病的高度認識、廣泛的治療選擇和有利的報銷方案而在全球市場佔據主導地位。

主要市場參與者有 Reddy Laboratories、SOM Biotech、Luye Pharma Group、Prestwick Pharmaceuticals、Sun Pharmaceuticals Industries、Allergan 等。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第 4 章：遲發性運動障礙治療的全球市場洞察

  • 遲發性運動障礙治療藥物市場 - 通路快照
  • 遲發性運動障礙藥物的市場動態
    • 驅動因素和機遇
      • 研究與開發工作
      • 遲發性運動障礙盛行率上升，公司專注於獲得產品批准
    • 限制因素和課題
      • 理解病理生理學的局限性
  • PESTEL 分析
  • 遲發性運動障礙治療藥物市場的通路趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第五章世界藥品市場

  • 主要發現
  • 介紹
  • 丁苯那秦
  • 纈苯那秦
  • 其他

第六章依產品類型劃分的全球市場

  • 主要發現
  • 介紹
  • 固體劑型
  • 藥片
  • 膠囊
  • 液體劑型
  • 注射

第七章依分銷通路劃分的世界市場

  • 主要發現
  • 介紹
  • 醫院藥房
  • 藥局和藥房
  • 網上藥店
  • 其他

第八章依地區劃分的世界市場

  • 主要發現
  • 介紹
    • 遲發性運動障礙治療藥物市場評估，地區，2019-2032
  • 遲發性運動障礙治療藥物市場－北美
    • 北美：遲發性運動障礙治療藥物市場（依藥物），2019-2032
    • 北美：遲發性運動障礙治療藥物市場，依通路劃分，2019-2032 年
    • 北美：遲發性運動障礙治療藥物市場，依產品類型，2019-2032
    • 遲發性運動障礙治療藥物市場—美國
    • 遲發性運動障礙藥物市場 - 加拿大
  • 遲發性運動障礙藥物市場 - 歐洲
    • 歐洲：遲發性運動障礙治療藥物市場（依藥物），2019-2032
    • 歐洲：遲發性運動障礙治療藥物市場，依通路劃分，2019-2032 年
    • 歐洲：遲發性運動障礙治療藥物市場，依產品類型，2019-2032
    • 遲發性運動障礙治療市場 - 英國
    • 遲發性運動障礙治療市場—法國
    • 遲發性運動障礙治療市場—德國
    • 遲發性運動障礙藥物市場—義大利
    • 遲發性運動障礙治療市場—西班牙
    • 遲發性運動障礙治療市場 - 荷蘭
    • 遲發性運動障礙治療市場—俄羅斯
  • 遲發性運動障礙治療藥物市場—亞太地區
    • 亞太地區：遲發性運動障礙治療市場（依藥物），2019-2032
    • 亞太地區：遲發性運動障礙治療藥物市場，依通路劃分，2019-2032 年
    • 亞太地區：遲發性運動障礙治療市場（依產品類型），2019-2032 年
    • 遲發性運動障礙治療藥物市場 - 中國
    • 遲發性運動障礙藥物市場 - 印度
    • 遲發性運動障礙治療市場 - 馬來西亞
    • 遲發性運動障礙治療藥物市場—日本
    • 遲發性運動障礙治療市場 - 印度尼西亞
    • 遲發性運動障礙治療藥物市場－韓國
  • 遲發性運動障礙治療藥物市場—中東和非洲
    • 中東和非洲：遲發性運動障礙治療藥物市場（依藥物），2019-2032
    • 中東和非洲：遲發性運動障礙治療藥物市場（依分銷管道），2019-2032
    • 中東和非洲：遲發性運動障礙治療藥物市場（依產品類型），2019-2032
    • 遲發性運動障礙治療市場 - 沙烏地阿拉伯
    • 遲發性運動障礙治療藥物市場 - 阿聯酋
    • 遲發性運動障礙藥物市場 - 以色列
    • 遲發性運動障礙治療市場 - 南非
  • 遲發性運動障礙治療藥物市場 - 拉丁美洲
    • 拉丁美洲：遲發性運動障礙治療市場（依藥物），2019-2032
    • 拉丁美洲：遲發性運動障礙治療藥物市場，依通路劃分，2019-2032 年
    • 拉丁美洲：遲發性運動障礙治療藥物市場（依產品類型），2019-2032 年
    • 遲發性運動障礙藥物市場—墨西哥
    • 遲發性運動障礙藥物市場 - 巴西
    • 遲發性運動障礙藥物市場 - 阿根廷

第9章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/出版物

第十章公司簡介

  • Allergan
  • Contera Pharma
  • Johnson & Johnson Services Inc.
  • Lannett Co. Inc
  • Luye Pharma Group
  • Mitsubishi Tanabe Pharma Corporation
  • Neurocrine Biosciences Inc.
  • Prestwick Pharmaceuticals Inc.
  • Reddy Laboratories Ltd.
  • SOM Biotech
  • SteriMax Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals
Product Code: PM4423

The global tardive dyskinesia therapeutics market size is expected to reach USD 5.57 billion by 2032, according to a new study by Polaris Market Research. The report "Tardive Dyskinesia Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug (Deutetrabenazine, Valbenazine, and Others); By Product Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The drastic increase in the prevalence of various neurological and psychotic disorders and growing need for disease-specific novel treatment, are the leading factors propelling market's growth. Additionally, increase in financial support to the researchers and health institutes for advancing the novel intervention and bring innovations in the healthcare sector including therapeutics for tardive dyskinesia, are further anticipated to drive market's growth.

For instance, in November 2023, Neurocrine Biosciences, introduced DISCOVER TD, which is an interactive digital tool specially designed to help healthcare providers learn and identify about the tardive dyskinesia. Tool is built in collaboration with the clinical experts.

The rising cases of mental illnesses across the globe which requires prolonged treatment with antipsychotic drugs that causes irregular dopamine, fostering the demand for effective therapeutics. Also, the growing adoption of neuropsychological testing for monitoring or detecting changes in cognitive function, identifying specific patterns, and speed of information processing, are also propelling the market's growth. For instance, as per a report by the Centers for Disease Control and Prevention, nearly 1 in 5 US adults live with some form of mental illness, & nearly1 in 5 youth have seriously debilitating mental illness during their life.

Furthermore, the guideline of the American Academy of Neurology was updated recently for incorporating 2 FDA-approved VMAT2 inhibitors including valbenazine & deutetrabenazine, which has been marked as a huge milestone because they had undergone multi-center, randomized, & double-blind clinical trials. They were the first one which is going to be supported by the level A evidence and were mainly approved for the treatment of tardive dyskinesia in the United States.

Tardive Dyskinesia Therapeutics Market Report Highlights

Valbenazine segment accounted for the noteworthy share, on account of rising number of awareness campaigns about such diseases and their therapeutics

Solid dosage form segment held the majority share, driven by its rising adoption by healthcare professionals and higher effectiveness of medication

Online pharmacies segment will grow at highest pace, due to rising number of online buyers and emergence of several online pharmacies for the remotest places

North America dominated the global market, owing to region's greater awareness about disease and wider availability of treatment options, coupled with positive reimbursement scenario

The key market players include Reddy Laboratories, SOM Biotech, Luye Pharma Group, Prestwick Pharmaceuticals, Sun Pharmaceuticals Industries, and Allergan

Polaris Market Research has segmented the tardive dyskinesia therapeutics market report based on drug, product type, distribution channel, and region:

Tardive Dyskinesia Therapeutics, Drug Outlook (Revenue - USD Billion, 2019 - 2032)

  • Deutetrabenazine
  • Valbenazine
  • Others

Tardive Dyskinesia Therapeutics, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Solid Dosage Forms
  • Tablets
  • Capsules
  • Liquid Dosage Form
  • Injection

Tardive Dyskinesia Therapeutics, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies
  • Others

Tardive Dyskinesia Therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Tardive Dyskinesia Therapeutics Market Insights

  • 4.1. Tardive Dyskinesia Therapeutics Market - Distribution Channel Snapshot
  • 4.2. Tardive Dyskinesia Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Research and Development Initiatives.
      • 4.2.1.2. Increasing prevalence of tardive dyskinesia and focus of companies on gaining product approvals are propelling market growth.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Understanding of Pathophysiology
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Tardive Dyskinesia Therapeutics Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Tardive Dyskinesia Therapeutics Market, by Drug

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • 5.3. Deutetrabenazine
    • 5.3.1. Global Tardive Dyskinesia Therapeutics Market, by Deutetrabenazine, by Region, 2019-2032 (USD Billion)
  • 5.4. Valbenazine
    • 5.4.1. Global Tardive Dyskinesia Therapeutics Market, by Valbenazine, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Tardive Dyskinesia Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Tardive Dyskinesia Therapeutics Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • 6.3. Solid Dosage Form
    • 6.3.1. Global Tardive Dyskinesia Therapeutics Market, by Solid Dosage Form, by Region, 2019-2032 (USD Billion)
  • 6.4. Tablets
    • 6.4.1. Global Tardive Dyskinesia Therapeutics Market, by Tablets, by Region, 2019-2032 (USD Billion)
  • 6.5. Capsules
    • 6.5.1. Global Tardive Dyskinesia Therapeutics Market, by Capsules, by Region, 2019-2032 (USD Billion)
  • 6.6. Liquid Dosage Form
    • 6.6.1. Global Tardive Dyskinesia Therapeutics Market, by Liquid Dosage Form, by Region, 2019-2032 (USD Billion)
  • 6.7. Injection
    • 6.7.1. Global Tardive Dyskinesia Therapeutics Market, by Injection, by Region, 2019-2032 (USD Billion)

7. Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospitals Pharmacies
    • 7.3.1. Global Tardive Dyskinesia Therapeutics Market, by Hospitals Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.4. Drug Stores & Retail Pharmacies
    • 7.4.1. Global Tardive Dyskinesia Therapeutics Market, by Drug Stores & Retail Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Tardive Dyskinesia Therapeutics Market, by Online Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Tardive Dyskinesia Therapeutics Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Tardive Dyskinesia Therapeutics Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Tardive Dyskinesia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Tardive Dyskinesia Therapeutics Market - North America
    • 8.3.1. North America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
    • 8.3.2. North America: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.4. Tardive Dyskinesia Therapeutics Market - U.S.
      • 8.3.4.1. U.S.: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.5. Tardive Dyskinesia Therapeutics Market - Canada
      • 8.3.5.1. Canada: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4. Tardive Dyskinesia Therapeutics Market - Europe
    • 8.4.1. Europe: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.4. Tardive Dyskinesia Therapeutics Market - UK
      • 8.4.4.1. UK: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.5. Tardive Dyskinesia Therapeutics Market - France
      • 8.4.5.1. France: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.6. Tardive Dyskinesia Therapeutics Market - Germany
      • 8.4.6.1. Germany: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.7. Tardive Dyskinesia Therapeutics Market - Italy
      • 8.4.7.1. Italy: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.8. Tardive Dyskinesia Therapeutics Market - Spain
      • 8.4.8.1. Spain: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.9. Tardive Dyskinesia Therapeutics Market - Netherlands
      • 8.4.9.1. Netherlands: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.10. Tardive Dyskinesia Therapeutics Market - Russia
      • 8.4.10.1. Russia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5. Tardive Dyskinesia Therapeutics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.4. Tardive Dyskinesia Therapeutics Market - China
      • 8.5.4.1. China: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.5. Tardive Dyskinesia Therapeutics Market - India
      • 8.5.5.1. India: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.6. Tardive Dyskinesia Therapeutics Market - Malaysia
      • 8.5.6.1. Malaysia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.7. Tardive Dyskinesia Therapeutics Market - Japan
      • 8.5.7.1. Japan: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.8. Tardive Dyskinesia Therapeutics Market - Indonesia
      • 8.5.8.1. Indonesia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.9. Tardive Dyskinesia Therapeutics Market - South Korea
      • 8.5.9.1. South Korea: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6. Tardive Dyskinesia Therapeutics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.4. Tardive Dyskinesia Therapeutics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.5. Tardive Dyskinesia Therapeutics Market - UAE
      • 8.6.5.1. UAE: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.6. Tardive Dyskinesia Therapeutics Market - Israel
      • 8.6.6.1. Israel: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.7. Tardive Dyskinesia Therapeutics Market - South Africa
      • 8.6.7.1. South Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7. Tardive Dyskinesia Therapeutics Market - Latin America
    • 8.7.1. Latin America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.4. Tardive Dyskinesia Therapeutics Market - Mexico
      • 8.7.4.1. Mexico: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.5. Tardive Dyskinesia Therapeutics Market - Brazil
      • 8.7.5.1. Brazil: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.6. Tardive Dyskinesia Therapeutics Market - Argentina
      • 8.7.6.1. Argentina: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Allergan
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Contera Pharma
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Johnson & Johnson Services Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Lannett Co. Inc
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Luye Pharma Group
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mitsubishi Tanabe Pharma Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Neurocrine Biosciences Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Prestwick Pharmaceuticals Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Reddy Laboratories Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. SOM Biotech
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. SteriMax Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sun Pharmaceutical Industries Ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Teva Pharmaceutical Industries Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Valeant Pharmaceuticals
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables

  • Table 1 Global Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 2 Global Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 3 Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Tardive Dyskinesia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 6 North America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 7 North America: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 9 U.S.: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 12 Canada: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 15 Europe: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 18 UK: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 19 UK: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 21 France: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 22 France: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 24 Germany: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 27 Italy: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 30 Spain: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 36 Russia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 42 China: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 43 China: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 45 India: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 46 India: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 51 Japan: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 57 South Korea: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 66 UAE: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 69 Israel: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 72 South Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 75 Latin America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 78 Mexico: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 81 Brazil: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
  • Table 84 Argentina: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Tardive Dyskinesia Therapeutics Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Tardive Dyskinesia Therapeutics Market, by Product Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Drug
  • Figure 9. Global Tardive Dyskinesia Therapeutics Market, by Drug, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Tardive Dyskinesia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Tardive Dyskinesia Therapeutics Market